1. Home
  2. UBCP vs JSPRW Comparison

UBCP vs JSPRW Comparison

Compare UBCP & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBCP
  • JSPRW
  • Stock Information
  • Founded
  • UBCP 1902
  • JSPRW N/A
  • Country
  • UBCP United States
  • JSPRW United States
  • Employees
  • UBCP N/A
  • JSPRW N/A
  • Industry
  • UBCP Major Banks
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBCP Finance
  • JSPRW Health Care
  • Exchange
  • UBCP Nasdaq
  • JSPRW Nasdaq
  • Market Cap
  • UBCP N/A
  • JSPRW N/A
  • IPO Year
  • UBCP N/A
  • JSPRW N/A
  • Fundamental
  • Price
  • UBCP $13.00
  • JSPRW $0.12
  • Analyst Decision
  • UBCP
  • JSPRW
  • Analyst Count
  • UBCP 0
  • JSPRW 0
  • Target Price
  • UBCP N/A
  • JSPRW N/A
  • AVG Volume (30 Days)
  • UBCP 4.4K
  • JSPRW 7.8K
  • Earning Date
  • UBCP 02-07-2025
  • JSPRW 03-05-2025
  • Dividend Yield
  • UBCP 6.58%
  • JSPRW N/A
  • EPS Growth
  • UBCP N/A
  • JSPRW N/A
  • EPS
  • UBCP 1.27
  • JSPRW N/A
  • Revenue
  • UBCP $28,831,592.00
  • JSPRW N/A
  • Revenue This Year
  • UBCP N/A
  • JSPRW N/A
  • Revenue Next Year
  • UBCP $3.00
  • JSPRW N/A
  • P/E Ratio
  • UBCP $10.24
  • JSPRW N/A
  • Revenue Growth
  • UBCP N/A
  • JSPRW N/A
  • 52 Week Low
  • UBCP $11.40
  • JSPRW $0.15
  • 52 Week High
  • UBCP $15.50
  • JSPRW $0.16
  • Technical
  • Relative Strength Index (RSI)
  • UBCP 51.04
  • JSPRW N/A
  • Support Level
  • UBCP $12.65
  • JSPRW N/A
  • Resistance Level
  • UBCP $13.46
  • JSPRW N/A
  • Average True Range (ATR)
  • UBCP 0.45
  • JSPRW 0.00
  • MACD
  • UBCP 0.01
  • JSPRW 0.00
  • Stochastic Oscillator
  • UBCP 61.98
  • JSPRW 0.00

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: